Oncotrace RGCC is used to identify a primary tumour in a patient and to provide guidance about disease progression and future prognosis.
During the test, a sample of blood is analysed to identify the presence and concentration of circulating tumour cells (CTCs) and their concentration. This test provides information about the presence of CTCs, their concentration and specific type (immunophenotype).
The results of the test enable clinicians to identify the origin of a tumour where this is unknown and to provide information on the development of cancer and the prognosis.
No. 9, Wisma Laxton, Jalan Desa,
Taman Desa,
58100 Kuala Lumpur, Malaysia.
Klang Branch
Lot 17, Jalan Gelugor, Bandar Klang, 41050 Klang, Selangor
Jakarta Branch
Jalan Panglima Polim XIV No 9 Jakarta 12160
US Branch
5852 Horton PlaceFayetteville North Carolina 28314
All Rights Reserved | WellLab
Designed by Trinity42